Can a postbiotic supplement ease aching joints? new trial investigates
NCT ID NCT07602426
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a postbiotic supplement called resO can help adults aged 18-75 with joint discomfort, stiffness, or reduced mobility. Forty participants will take either resO or a placebo for 4 weeks, and researchers will measure changes in physical function, pain, and activity using questionnaires. The goal is to see if resO improves daily movement and reduces pain interference compared to placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- postbiotic supplement (resO)
- What this could lead to
- If it works, this could point toward a natural supplement option for easing joint discomfort and improving daily mobility.
- What could go wrong
- This is a small, early-stage trial with only 40 participants and a short 4-week duration. Results may not apply to everyone, and the supplement may not outperform placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JOINT DISCOMFORT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Able Biolabs LLC
Dallas, Texas, 75247, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can targeted neck exercises outperform standard stretching?
- Can a desk workout plus pilates beat the office aches?
- Can physical therapy with a psychological twist tame ER back pain?
- Can a peptide gummy soothe sore muscles and speed recovery?
- Can tape or therapy soothe Post-COVID back pain?
- Five minutes a day to stronger legs? a trial puts brief daily training to the test in older adults